Pregabalin Sandoz GmbH 欧州連合 - ラトビア語 - EMA (European Medicines Agency)

pregabalin sandoz gmbh

sandoz gmbh - pregabalin - anxiety disorders; epilepsy - antiepileptics, - epilepsypregabalin sandoz gmbh ir norādīts kā adjunctive terapija pieaugušajiem ar daļēju lēkmju ar vai bez sekundāras vispārināšanas. Ģeneralizēta trauksme disorderpregabalin sandoz gmbh ir indicēts, lai ārstētu Ģeneralizēta trauksme (vsd) pieaugušajiem.

Pregabalin Zentiva 欧州連合 - ラトビア語 - EMA (European Medicines Agency)

pregabalin zentiva

zentiva, k.s. - pregabalin - anxiety disorders; epilepsy - antiepileptics, - neuropathic pain , pregabalin zentiva is indicated for the treatment of peripheral and central neuropathic pain in adults. , epilepsy , pregabalin zentiva is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation. , generalised anxiety disorder , pregabalin zentiva is indicated for the treatment of generalised anxiety disorder (gad) in adults.

Volibris 欧州連合 - ラトビア語 - EMA (European Medicines Agency)

volibris

glaxosmithkline (ireland) limited - ambrisentan - hipertensija, plaušu slimība - antihipertensīvie līdzekļi, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5.  efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.

Hemlibra 欧州連合 - ラトビア語 - EMA (European Medicines Agency)

hemlibra

roche registration limited - emicizumabs - a hemofīlija - antihemorāģija - hemlibra is indicated for routine prophylaxis of bleeding episodes in patients with haemophilia a (congenital factor viii deficiency):with factor viii inhibitorswithout factor viii inhibitors who have:severe disease (fviii < 1%)moderate disease (fviii ≥ 1% and ≤ 5%) with severe bleeding phenotype. hemlibra var izmantot visās vecuma grupās.

Gelofusine šķīdums infūzijām ラトビア - ラトビア語 - Zāļu valsts aģentūra

gelofusine šķīdums infūzijām

b.braun melsungen ag, germany - gelatinum succinas, natrii chloridum, natrii hydroxidum - Šķīdums infūzijām

Latalux 50 mikrogrami/ml acu pilieni, šķīdums ラトビア - ラトビア語 - Zāļu valsts aģentūra

latalux 50 mikrogrami/ml acu pilieni, šķīdums

bausch + lomb ireland limited, ireland - latanoprosts - acu pilieni, šķīdums - 50 μg/ml

Siranalen 150 mg cietās kapsulas ラトビア - ラトビア語 - Zāļu valsts aģentūra

siranalen 150 mg cietās kapsulas

medochemie ltd., cyprus - pregabalīns - kapsula, cietā - 150 mg

Siranalen 75 mg cietās kapsulas ラトビア - ラトビア語 - Zāļu valsts aģentūra

siranalen 75 mg cietās kapsulas

medochemie ltd., cyprus - pregabalīns - kapsula, cietā - 75 mg

Flamerio 50 mikrogrami/250 mikrogrami/devā inhalācijas pulveris, dozēts ラトビア - ラトビア語 - Zāļu valsts aģentūra

flamerio 50 mikrogrami/250 mikrogrami/devā inhalācijas pulveris, dozēts

elpen pharmaceutical co. inc (sa), greece - salmeterolum, fluticasoni propionas - inhalācijas pulveris, dozēts - 50 mikrogrami/250 mikrogrami/devā

Pregamid 50 mg cietās kapsulas ラトビア - ラトビア語 - Zāļu valsts aģentūra

pregamid 50 mg cietās kapsulas

g.l. pharma gmbh, austria - pregabalīns - kapsula, cietā - 50 mg